OnCore Login

Return to Trial Database

GU07-123

Phase II Trial of Neoadjuvant Cisplatin, Gemcitabine and Sunitinib Malate Followed by Radical Cystectomy for Transitional Cell Carcinoma (TCC) of the Bladder

Status

Study Completed

Cancer Type(s)

Bladder

Study Contact

Publications

A Phase II Trial of Neoadjuvant Cisplatin (C), Gemcitabine (G), and Sunitinib (S) in Muscle-Invasive Urothelial Carcinoma (miUC)
  • S Lerner, NM Hahn, T Powles, TA Gardner, L Cheng, JS Green, DM Berney, D Taber, J Hudak, J Landgraf, S Shen, G Sonpavde

Trial Locations

All sites in which the trial GU07-123 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278